Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Solid stress estimations via intraoperative 3D navigation in patients with brain tumors
- Neuro-Oncology and Radiogenomics: Time to Integrate?
- Higher vascularity at infiltrated peripheral edema differentiates proneural glioblastoma subtype
- Tumor cell phenotype and heterogeneity differences in IDH1 mutant vs wild-type gliomas
- Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research
- Clinically Relevant Imaging Features for MGMT Promoter Methylation in Multiple Glioblastoma Studies: A Systematic Review and Meta-Analysis
- Deep-Learning Convolutional Neural Networks Accurately Classify Genetic Mutations in Gliomas
- MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication
- T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project
- Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging
- Radiologic Features and Expression of Vascular Endothelial Growth Factor Stratify Survival Outcomes in Patients with Glioblastoma
- Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
- MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status
- Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation
- Potential Role of Preoperative Conventional MRI Including Diffusion Measurements in Assessing Epidermal Growth Factor Receptor Gene Amplification Status in Patients with Glioblastoma
- Probabilistic Radiographic Atlas of Glioblastoma Phenotypes